Contributions of 2-h post-load glucose, fasting blood glucose and glycosylated haemoglobin elevations to the prevalence of diabetes and pre-diabetes in adults: A systematic analysis of global data.
Saved in:
| Title: | Contributions of 2-h post-load glucose, fasting blood glucose and glycosylated haemoglobin elevations to the prevalence of diabetes and pre-diabetes in adults: A systematic analysis of global data. |
|---|---|
| Authors: | Xue X; Department of Nephrology and Hubei Shizhen Laboratory, Affiliated Hospital of Hubei University of Chinese Medicine, Hubei Provincial Hospital of Traditional Chinese Medicine, Wuhan, Hubei, China.; The Jockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, China., Li J; Department of Nephrology and Hubei Shizhen Laboratory, Affiliated Hospital of Hubei University of Chinese Medicine, Hubei Provincial Hospital of Traditional Chinese Medicine, Wuhan, Hubei, China., Zheng W; The Jockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, China., Zhang B; Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China., Wang S; The Jockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, China., Zhang J; Faculty of Medicine, Macau University of Science and Technology, Macao Special Administrative Region, China., Yang Z; The Jockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, China. |
| Source: | Diabetes, obesity & metabolism [Diabetes Obes Metab] 2025 Dec; Vol. 27 (12), pp. 7285-7298. Date of Electronic Publication: 2025 Sep 15. |
| Publication Type: | Journal Article; Systematic Review |
| Language: | English |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 100883645 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1463-1326 (Electronic) Linking ISSN: 14628902 NLM ISO Abbreviation: Diabetes Obes Metab Subsets: MEDLINE |
| Imprint Name(s): | Original Publication: Oxford : Wiley-Blackwell, c1999- |
| MeSH Terms: | Glycated Hemoglobin*/analysis , Glycated Hemoglobin*/metabolism , Prediabetic State*/epidemiology , Prediabetic State*/blood , Prediabetic State*/diagnosis , Blood Glucose*/analysis , Blood Glucose*/metabolism , Fasting*/blood , Diabetes Mellitus, Type 2*/epidemiology , Diabetes Mellitus, Type 2*/blood , Diabetes Mellitus, Type 2*/diagnosis , Diabetes Mellitus*/epidemiology , Diabetes Mellitus*/blood, Humans ; Prevalence ; Adult ; Glucose Tolerance Test ; Female ; Male ; Middle Aged ; Global Health |
| Abstract: | Aims: Some studies found that the association of fasting blood glucose (FPG) or glycosylated haemoglobin (HbA1c) elevation with diabetic complications was not statistically significant after controlling for the confounding caused by 2-h post-load glucose (2hPG) elevation. Furthermore, inclusion of HbA1c as a diagnostic measure for diabetes has raised some concerns about over-diagnosis and over-treatment. This study aimed to quantify the contributions of 2hPG, FPG and HbA1c elevations to the prevalence of diabetes and pre-diabetes respectively, by synthesising global data, which can serve as essential parameters in cost-effectiveness analysis and inform updates of practice guidelines about prevention and control of diabetes. Materials and Methods: The levels of 2hPG, FPG and HbA1c were classified as either 'elevated' or 'normal.' Each distinct combination of these markers (e.g., 'elevated 2hPG, normal FPG and normal HbA1c') defined a unique subgroup, resulting in a total of seven subgroups for both diabetes and pre-diabetes. The contribution of 2hPG elevation to diabetes prevalence was calculated as its proportion among all diabetes cases; the same approach was applied to FPG and HbA1c elevations, as well as to pre-diabetes prevalence. To retrieve global data, five electronic databases (i.e., PubMed, EMBASE, Web of Science, China National Knowledge Infrastructure and Wan Fang) were searched from their inception to February 2024. Studies that fulfilled the following criteria were considered eligible: (1) were conducted in adults without previously diagnosed diabetes; (2) were cross-sectional studies or baseline surveys of cohort studies (which can be regarded as a special type of cross-sectional studies); and (3) reported directly or allowed for calculation of the proportion of each subgroup out of all diabetes and/or the proportion of each subgroup out of all pre-diabetes. A 10-item tool selected from literature was used to appraise the quality of included data. The proportions of each subgroup among all diabetes cases were meta-analysed across eligible studies with the random-effects model using the MetaXL software. Similar meta-analyses were conducted for pre-diabetes. Results: Thirty-two eligible studies were identified, with 25 reporting on newly detected diabetes (n = 289 094) and 15 on pre-diabetes (n = 221 988) and the majority of them using identical diagnostic cutoffs proposed by the American Diabetes Association (ADA). The mean age of participants ranged from 24 to 68 years (median of mean ages: 51). Twenty-four studies (75%) were assessed as at low risk for ≥7 out of the 10 quality items. In the general population, based on the ADA criteria, the weighted prevalence of diabetes and pre-diabetes was 15% and 69%, respectively. Among those with newly detected diabetes (n = 24 214), 69% had elevated 2hPG, 44% elevated FPG and 61% elevated HbA1c; 7% had isolated FPG elevation; 20% had isolated HbA1c elevation. Among those with newly detected pre-diabetes (n = 133 621), 33% had elevated 2hPG, 51% elevated FPG and 68% elevated HbA1c; 17% had isolated FPG elevation; 34% had isolated HbA1c elevation. Sensitivity analyses stratified by participant comorbidities and study quality produced results consistent with the main findings. Conclusions: The largest contributors to the prevalence of diabetes and pre-diabetes are 2hPG and HbA1c, respectively. Isolated FPG and HbA1c elevations account for over a quarter of all diabetes and more than half of all pre-diabetes. (© 2025 The Author(s). Diabetes, Obesity and Metabolism published by John Wiley & Sons Ltd.) |
| References: | PLoS One. 2014 Oct 06;9(10):e109506. (PMID: 25285769) Exp Clin Endocrinol Diabetes. 2017 Apr;125(4):251-255. (PMID: 28081577) Diabetologia. 2002 Apr;45(4):461-75. (PMID: 12032622) Diabetes Res Clin Pract. 2021 Mar;173:108672. (PMID: 33485867) Prim Care Diabetes. 2023 Oct;17(5):506-512. (PMID: 37321876) Diabetes Res Clin Pract. 2020 Nov;169:108475. (PMID: 33002547) Diabetes Technol Ther. 2012 Aug;14(8):665-8. (PMID: 22823754) J Diabetes. 2016 May;8(3):378-86. (PMID: 25940519) Diabet Med. 2002 Sep;19(9):708-23. (PMID: 12207806) Diabetol Metab Syndr. 2014 Mar 27;6(1):44. (PMID: 24673860) J Gen Intern Med. 2014 Feb;29(2):388-94. (PMID: 24002631) Ann Med. 2012 Mar;44(2):170-7. (PMID: 21091229) World Health Organ Tech Rep Ser. 1980;646:1-80. (PMID: 6771926) AIDS Res Ther. 2020 May 24;17(1):25. (PMID: 32448349) BMJ. 2016 Nov 23;355:i5953. (PMID: 27881363) Diabetes Care. 2025 Jan 1;48(1 Suppl 1):S50-S58. (PMID: 39651971) Diabetes Care. 2011 Oct;34(10):2314-6. (PMID: 21816975) BMJ. 2021 Mar 29;372:n71. (PMID: 33782057) Clin Chim Acta. 2015 May 20;445:48-53. (PMID: 25797896) Diabetes Res Clin Pract. 2019 Jul;153:93-102. (PMID: 31150721) Nutrients. 2019 Nov 01;11(11):. (PMID: 31683759) Diabet Med. 2011 May;28(5):567-74. (PMID: 21480967) J Clin Epidemiol. 2012 Sep;65(9):934-9. (PMID: 22742910) Diabetes Care. 1997 Jul;20(7):1183-97. (PMID: 9203460) J Stroke Cerebrovasc Dis. 2018 May;27(5):1127-1133. (PMID: 29605383) Diabetes Care. 2025 Jan 1;48(1 Suppl 1):S27-S49. (PMID: 39651986) Indian J Endocrinol Metab. 2018 Jan-Feb;22(1):50-56. (PMID: 29535937) Diabetes Obes Metab. 2025 Dec;27(12):7285-7298. (PMID: 40954930) Diabetes Care. 2021 Jan;44(Suppl 1):S221-S222. (PMID: 33298427) Biomed Res Int. 2018 May 22;2018:8358724. (PMID: 29951547) Diabetes Res Clin Pract. 2010 Mar;87(3):415-21. (PMID: 20061043) Diabetes Metab Syndr. 2017 Oct - Dec;11(4):251-255. (PMID: 27623517) Gynecol Endocrinol. 2013 Jul;29(7):687-90. (PMID: 23638620) Diabet Med. 2015 Sep;32(9):1207-11. (PMID: 25594838) Arch Intern Med. 2001 Feb 12;161(3):397-405. (PMID: 11176766) J Diabetes Complications. 2017 May;31(5):814-823. (PMID: 28319002) Diabetes Res Clin Pract. 2011 Feb;91(2):e53-6. (PMID: 21185103) Diabetes Care. 2010 Dec;33(12):2626-8. (PMID: 20833866) Diabet Med. 2011 Oct;28(10):1234-7. (PMID: 21429007) Clin Chem Lab Med. 2015 Aug;53(9):1441-9. (PMID: 25405720) World Health Organ Tech Rep Ser. 1965;310:1-44. (PMID: 4953441) Science. 2019 Mar 8;363(6431):1026-1031. (PMID: 30846581) Diabetes Care. 2011 Oct;34(10):2237-43. (PMID: 21949221) Eur Heart J. 2015 May 14;36(19):1171-7. (PMID: 25670820) Diabetes Metab Syndr. 2025 Jan;19(1):103184. (PMID: 39778431) Clin Exp Obstet Gynecol. 2014;41(1):58-61. (PMID: 24707685) BMC Infect Dis. 2018 Jul 6;18(1):309. (PMID: 29980190) Am J Prev Med. 2023 Nov;65(5):906-915. (PMID: 37217038) Mol Aspects Med. 2015 Dec;46:21-33. (PMID: 26549348) Ann Thorac Surg. 2010 May;89(5):1482-7. (PMID: 20417764) J Epidemiol Community Health. 2013 Nov 1;67(11):974-8. (PMID: 23963506) Diabetes Care. 2019 Aug;42(8):1539-1548. (PMID: 31152120) Endocr Pract. 2011 Mar-Apr;17(2):210-7. (PMID: 20841311) Front Endocrinol (Lausanne). 2023 Mar 28;14:1149239. (PMID: 37056675) |
| Grant Information: | The Chinese University of Hong Kong; Teaching Development and Language Enhancement Grant 2022-2025 |
| Contributed Indexing: | Keywords: 2‐h post‐load glucose; diabetes; fasting blood glucose; glycosylated haemoglobin; prevalence; pre‐diabetes; systematic review |
| Substance Nomenclature: | 0 (Glycated Hemoglobin) 0 (Blood Glucose) 0 (hemoglobin A1c protein, human) |
| Entry Date(s): | Date Created: 20250916 Date Completed: 20251105 Latest Revision: 20251107 |
| Update Code: | 20251107 |
| PubMed Central ID: | PMC12587253 |
| DOI: | 10.1111/dom.70130 |
| PMID: | 40954930 |
| Database: | MEDLINE |
Full Text Finder 
Nájsť tento článok vo Web of Science | Abstract: | Aims: Some studies found that the association of fasting blood glucose (FPG) or glycosylated haemoglobin (HbA1c) elevation with diabetic complications was not statistically significant after controlling for the confounding caused by 2-h post-load glucose (2hPG) elevation. Furthermore, inclusion of HbA1c as a diagnostic measure for diabetes has raised some concerns about over-diagnosis and over-treatment. This study aimed to quantify the contributions of 2hPG, FPG and HbA1c elevations to the prevalence of diabetes and pre-diabetes respectively, by synthesising global data, which can serve as essential parameters in cost-effectiveness analysis and inform updates of practice guidelines about prevention and control of diabetes.<br />Materials and Methods: The levels of 2hPG, FPG and HbA1c were classified as either 'elevated' or 'normal.' Each distinct combination of these markers (e.g., 'elevated 2hPG, normal FPG and normal HbA1c') defined a unique subgroup, resulting in a total of seven subgroups for both diabetes and pre-diabetes. The contribution of 2hPG elevation to diabetes prevalence was calculated as its proportion among all diabetes cases; the same approach was applied to FPG and HbA1c elevations, as well as to pre-diabetes prevalence. To retrieve global data, five electronic databases (i.e., PubMed, EMBASE, Web of Science, China National Knowledge Infrastructure and Wan Fang) were searched from their inception to February 2024. Studies that fulfilled the following criteria were considered eligible: (1) were conducted in adults without previously diagnosed diabetes; (2) were cross-sectional studies or baseline surveys of cohort studies (which can be regarded as a special type of cross-sectional studies); and (3) reported directly or allowed for calculation of the proportion of each subgroup out of all diabetes and/or the proportion of each subgroup out of all pre-diabetes. A 10-item tool selected from literature was used to appraise the quality of included data. The proportions of each subgroup among all diabetes cases were meta-analysed across eligible studies with the random-effects model using the MetaXL software. Similar meta-analyses were conducted for pre-diabetes.<br />Results: Thirty-two eligible studies were identified, with 25 reporting on newly detected diabetes (n = 289 094) and 15 on pre-diabetes (n = 221 988) and the majority of them using identical diagnostic cutoffs proposed by the American Diabetes Association (ADA). The mean age of participants ranged from 24 to 68 years (median of mean ages: 51). Twenty-four studies (75%) were assessed as at low risk for ≥7 out of the 10 quality items. In the general population, based on the ADA criteria, the weighted prevalence of diabetes and pre-diabetes was 15% and 69%, respectively. Among those with newly detected diabetes (n = 24 214), 69% had elevated 2hPG, 44% elevated FPG and 61% elevated HbA1c; 7% had isolated FPG elevation; 20% had isolated HbA1c elevation. Among those with newly detected pre-diabetes (n = 133 621), 33% had elevated 2hPG, 51% elevated FPG and 68% elevated HbA1c; 17% had isolated FPG elevation; 34% had isolated HbA1c elevation. Sensitivity analyses stratified by participant comorbidities and study quality produced results consistent with the main findings.<br />Conclusions: The largest contributors to the prevalence of diabetes and pre-diabetes are 2hPG and HbA1c, respectively. Isolated FPG and HbA1c elevations account for over a quarter of all diabetes and more than half of all pre-diabetes.<br /> (© 2025 The Author(s). Diabetes, Obesity and Metabolism published by John Wiley & Sons Ltd.) |
|---|---|
| ISSN: | 1463-1326 |
| DOI: | 10.1111/dom.70130 |